MedPath

Comparison of Supraneural and Infraneural Transforaminal nerve root injections using ultrasound and Flouroscopic confirmatio

Phase 1
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/03/064338
Lead Sponsor
Dr RPGMC KANGRA at tanda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either gender between the ages of 18 – 70 years.

2.Patients with BMI between 18 and 35.

3.Patients with ASA grading I & II

4.Patients with back pain of discogenic origin, with or without discomfort to the particular dermatomal distribution, whose activities are restricted for at least six weeks and who do not respond to conservative treatment.

5.Neurogenic claudication.

6.MRI results indicating a nerve root involvement or a positive laesegue sign.

Exclusion Criteria

1.Patients who refuse to give consent.

2.Patients with diagnosed CVA with unilateral or bilateral neurological deficit.

3.Patients with Segmental instability.

4.Patients with severe degenerative disc disease with more than 2/3rd of disc height decreased.

5.Patients allergic to the drugs we use.

6.Active infection at the site of injection.

7.Pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fluoroscopic assessment of feasibility, accuracy & safety of ultrasound guided supraneural & infraneural transforaminal nerve root injectionsTimepoint: During Procedure
Secondary Outcome Measures
NameTimeMethod
1.To assess the accuracy of USG guided needle placement by fluoroscopy. <br/ ><br>2.To assess the Pain relief by verbal numeric pain scale <br/ ><br>3.Patient satisfaction in view of return to his/her routine work. <br/ ><br>4.To assess the complications i.e. accidental intra- vascular, intraneural or subarachanoiod injection associated with US-guided transforaminal nerve root injections. <br/ ><br> <br/ ><br>Timepoint: 2 hours after the <br/ ><br>procedure, 1 week, 3 weeks, 6 weeks & 3 months
© Copyright 2025. All Rights Reserved by MedPath